Yadong Group was established in 1991 and has a history of more than 30 years. It is a modern pharmaceutical production enterprise integrating production, research and development, and sales of one-class biopharmaceuticals (vaccines), Chinese traditional Chinese medicine, and chemical drugs. At present, there are six major production bases, including Changping, Daxing, and Anguo.

The group has a strong R&D capability and currently has more than 230 drug approvals. The drugs cover 15 major categories, including vaccines, liver disease, gynecology, pediatrics, tumors, cardiovascular and cerebrovascular diseases, etc. And has 220 authorized invention patents. The R & D project won one first-class prize of the National Science and Technology Progress Award and one third-class prize of the State Science and Technology Progress Award.